|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Evaluation of hematologic profile may be needed for patients treated with oxcarbazepine|
|Gu Hyun Jung, Su Jeong You|
Clin Exp Pediatr. 2019;62(8):312-316. Published online April 11, 2019
Evaluation of hematologic profile may be needed for patients treated with oxcarbazepine
IS ESTABLISHING AN APPROPRIATE BLEEDING RISK PROFILE IN ELDERLY PATIENTS TREATED WITH LOW-MOLECULAR-WEIGHT HEPARINS NEEDED?
Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy
Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal®) on a named-patient basis
Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
Safety profile of oxcarbazepine: Results from a prescription-event monitoring study
Evaluation of the Implementation of a Rapid Response Treatment Protocol for Patients with Acute Onset Stroke: Can We Increase the Number of Patients Treated and Shorten the Time Needed
Perioperative Evaluation of Patients with Hematologic Disorders
Infections in Patients with Hematologic Malignancies Treated with Monoclonal Antineoplastic Therapy
732 Pathological T2b and T2c subgrouping may not be needed for predicting biochemical relapse in patients treated by radical prostatectomy